Oxybuprocaine Hydrochloride Agepha 4 Mg/Ml

Oxybuprocaine hydrochloride, the active ingredient in Oxybuprocaine Hydrochloride Agepha 4 Mg/Ml, is a local anesthetic presented as a 4 mg/ml ophthalmic solution for topical ocular use. It is employed to achieve surface anesthesia of the eye for diagnostic and minor surgical procedures. GNH USA supplies Oxybuprocaine Hydrochloride Agepha 4 Mg/Ml as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxybuprocaine Hydrochloride Agepha 4 Mg/Ml as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Oxybuprocaine hydrochloride is a topical ocular anesthetic that provides rapid surface numbness for eye examinations and minor procedures. - Corneal abrasion assessment: facilitates painless examination of the cornea. - Intra‑ocular pressure measurement: enables comfortable tonometry. - Minor ocular surgery (e.g., foreign‑body removal): provides short‑lasting anesthesia. - Diagnostic fluorescein staining: improves patient comfort during staining. - Laser photocoagulation preparation: numbs the ocular surface before laser application.

Oxybuprocaine hydrochloride may cause transient ocular reactions following topical application.

Common Side Effects: - Burning or stinging sensation on instillation. - Temporary blurred vision. - Mild conjunctival hyperemia. - Tearing or lacrimation. - Foreign‑body sensation.

Serious or Rare Side Effects: - Corneal epithelial toxicity or ulceration. - Persistent epithelial defect. - Allergic contact dermatitis of the eyelid skin. - Severe ocular inflammation. - Vision loss (very rare).

When using Oxybuprocaine Hydrochloride Agepha, consider the following safety measures: - Contraindication: Do not use in patients with known hypersensitivity to oxybuprocaine or related ester‑type anesthetics. - Frequency: Limit applications to the number and interval recommended by the prescriber to avoid cumulative toxicity. - Contact lenses: Advise patients to remove contact lenses before instillation and avoid re‑insertion until the drug is cleared. - Monitoring: Observe for signs of corneal epithelial damage, especially with repeated use. - Storage: Store at ambient temperature: keep in the original container, protect from light and moisture.

Oxybuprocaine hydrochloride may interact with other ophthalmic agents, potentially altering efficacy or safety.

Major Interactions (Avoid): - Co‑administration with phenyl‑phen t t          ...  ....  ....  ...  t  ....  t t t t t  t  t  t.

Major Interaction (  t  t.

t  t.

t t.

Moderate Interactions (Monitor Closely): -  t \